Gyrodyne
GYRO
9 hedge funds and large institutions have $8.26M invested in Gyrodyne in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
16% more capital invested
Capital invested by funds: $7.15M → $8.26M (+$1.11M)
0.92% less ownership
Funds ownership: 42.08% → 41.17% (-0.92%)
10% less funds holding
Funds holding: 10 → 9 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GF
Gabelli Funds
Rye,
New York
|
+$19.3K |
| 2 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$1.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$185K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GF
1
Gabelli Funds
Rye,
New York
| $2.02M | +$19.3K | +1,547 | +1% |
|
|
GCIA
2
Gabelli & Co Investment Advisers
Rye,
New York
| $1.55M | +$1.25K | +100 | +0.1% |
|
|
TL
3
TowerView LLC
New York
| $1.42M | – | – | – |
|
|
4
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
| $1.39M | -$185K | -14,854 | -11% |
|
|
MFP
5
Michael F. Price
| $1.2M | – | – | – |
|
|
CL
6
CSS LLC
Chicago,
Illinois
| $427K | – | – | – |
|
|
TA
7
Teton Advisors
Rye,
New York
| $226K | – | – | – |
|
8
Morgan Stanley
New York
| $11K | – | – | – |
|
|
BBPWM
9
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $9K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | -$4K | -341 | Closed |
|
GYRO Hedge Fund Activity: Q1 2022 in Review
9 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Gyrodyne (GYRO) for Q1 2022, worth a combined $8.26M — up 16% from $7.15M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of GYRO and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was Gabelli Funds, adding an estimated $19.3K. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $185K.
- 9 institutional investors held Gyrodyne (GYRO) as of Q1 2022, down from 10 in Q4 2021.
- Funds reported $8.26M of Gyrodyne stock for Q1 2022, up 16% quarter-over-quarter.
- 0 funds opened new Gyrodyne positions in Q1 2022 and 1 closed out, a net change of -1 holder.
- The largest Gyrodyne buyer in Q1 2022 was Gabelli Funds, an estimated $19.3K added.
- The largest Gyrodyne seller in Q1 2022 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $185K sold.
Based on aggregated 13F filings for Q1 2022.